enEvolv: EnEvolv Raises $1.8 Million
According to an SEC filing, EnEvolv Inc. has raised $1.8 million via sale of shares to 13 investors. Cambridge-based enEvolv, founded in 2011, is developing genome
Read full article »
EnEvolv develops a microbial screening platform that utilizes sensor systems for the development of enzymes and molecules.
Read more